/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

X

Xenofon Baraliakos

University Hospitals of the Ruhr-University of Bochum(DE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

1.0K

Papers

32.0K

Citations

85

h-index

323

i10-index

Xenofon Baraliakos is an academic researcher from University Hospitals of the Ruhr-University of Bochum. The author has contributed to research in topics: Spondyloarthritis Studies and Treatments & Rheumatoid Arthritis Research and Therapies & Psoriasis: Treatment and Pathogenesis. The author has an h-index of 85, co-authored 861 publications.

ORCID: 0000-0002-9475-9362

Research Topics

Spondyloarthritis Studies and Treatments Rheumatoid Arthritis Research and Therapies Psoriasis: Treatment and Pathogenesis Bone and Joint Diseases Autoimmune and Inflammatory Disorders Research

Papers by this author

works

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

2020 · Annals of the Rheumatic Diseases · 935 citations

https://doi.org/10.1136/annrheumdis-2020-217159

Laure Gossec Xenofon Baraliakos Andreas Kerschbaumer Maarten de Wit

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

2022 · Annals of the Rheumatic Diseases · 832 citations

https://doi.org/10.1136/ard-2022-223296

Sofía Ramiro Elena Nikiphorou Alexandre Sepriano Augusta Ortolan

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

2024 · Annals of the Rheumatic Diseases · 283 citations

https://doi.org/10.1136/ard-2024-225531

Laure Gossec Andreas Kerschbaumer Ricardo J O Ferreira Daniel Aletaha

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

2005 · Arthritis Research & Therapy · 262 citations

https://doi.org/10.1186/ar1693

Xenofon Baraliakos Joachim Listing J. Brandt Martín Rudwaleit

TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort

2017 · Annals of the Rheumatic Diseases · 256 citations

https://doi.org/10.1136/annrheumdis-2017-211544

Christoph Molnar Almut Scherer Xenofon Baraliakos Manouk de Hooge

Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study

2021 · Annals of the Rheumatic Diseases · 239 citations

https://doi.org/10.1136/annrheumdis-2020-219601

Atul Deodhar Paula Śliwińska-Stańczyk Huji Xu Xenofon Baraliakos

Research topics

topics

Spondyloarthritis Studies and Treatments

Rheumatoid Arthritis Research and Therapies

Psoriasis: Treatment and Pathogenesis

Bone and Joint Diseases

Autoimmune and Inflammatory Disorders Research

Chat about Author

Papers

Chat

Click to start Chat